Dravet Syndrome Foundation (DSF) – Collaborative research efforts using genetic approach

DSF invites collaborative applications proposing gene therapy, upregulation, or other disease-modifying approaches which are likely to lead to the highly effective treatment of Dravet syndrome and its comorbidities.
Funding: USD 100,000/year up to two years. No overhead
Nonprofit - Please contact Research Authority if planning to submit.

https://www.dravetfoundation.org/rfa/